fluorobenzenes has been researched along with Constriction, Pathological in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calise, D; Cognet, T; Guilbeau-Frugier, C; Lairez, O; Mialet-Perez, J; Parini, A; Schaak, S | 1 |
| Bleske, BE; Boluyt, MO; Cirrincione, GM; Hwang, HS | 1 |
2 other study(ies) available for fluorobenzenes and Constriction, Pathological
| Article | Year |
|---|---|
Role of serotonin 5-HT2A receptors in the development of cardiac hypertrophy in response to aortic constriction in mice.
Topics: Age Factors; Analysis of Variance; Animals; Aorta; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiomegaly; Constriction, Pathologic; Disease Models, Animal; Echocardiography; Fluorobenzenes; Gene Expression Regulation; Hemodynamics; Histone Deacetylases; Male; Mice; Mice, Inbred C57BL; Myocardium; Piperidines; Receptor, Serotonin, 5-HT2A; RNA, Messenger; Serotonin Antagonists | 2013 |
3-HMG-Coenzyme A reductase inhibition and extracellular matrix gene expression in the pressure-overloaded rat heart.
Topics: Animals; Aorta, Thoracic; Blood Pressure; Blotting, Western; Body Weight; Cardiomegaly; Collagen; Constriction, Pathologic; DNA Probes; Extracellular Matrix; Fibronectins; Fluorobenzenes; Gene Expression; Heart; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Organ Size; Pyrimidines; Rats; Rats, Sprague-Dawley; RNA; Rosuvastatin Calcium; Sulfonamides; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Function, Left; Ventricular Remodeling | 2006 |